This article is intended for educational purposes, providing an overview of retatrutide, its mechanisms, current clinical evidence, and key considerations before use
23 Importantly, Mazdutide, a GLP-1/GCGR dual agonist, has shown promising outcomes in recent clinical trials, offering a unique mechanism that enhances fat oxidation, energy expenditure, and liver-fat reduction
When tested in patients with type 2 diabetes, Efendic had noticed that they lost more weight than when just on insulin (Phelan
Custom note concepts could include in-depth diet/nutritional information, behavioral interventions attempted for weight loss, as well as side effects from medication use
Alcohol: GLP-1 medications change how your body processes alcohol